we discuss several aspects of diagnosis and treatment in patients with diabetes and CKD based on the evidence-based clinical practice guidelines issued by the Kidney
” [26] should be considered and the integration of recommendations for PRO assessment into those guidelines discussed. Hereby, we present a reflection on and propose recommendations for the incorporation of PROs into future clinical practice guidelines for managing diabetes, obesity, CVD and CKD....
The new KDOQITM clinical practice guidelines and clinical practice recommendations for diabetes and CKD. Blood Purif. 2007;25:112-4.Robert G Nelson,Katherine R Tuttle.The New KDOQITM Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and CKD.Blood Purification. 2007...
This article offers insights into laboratory evidence of CKD and guidelines to enhance CKD diagnosis and management in T2D patients. 2. Methodology During 2022, an external task force of pharmacists, representatives of patient groups, and seven practitioners from France in general medicine, cardiology,...
It does not depart fromprior diabetes guidelines, but it does provide advice for specific situations relevant to CKD, such as the limitations of A1c when estimated glomerular filtration rate (eGFR) drops below 30 mL/min/1.73m2, and dietary protein consumption. It is based on published evidence ...
(2023) evaluated patients from the Cleveland Clinic with CKD (n = 122,276), CKD + T2DM (n = 35,255), and T2DM only (n = 63,643).4 Utilization rates of ACEis/ARBs and SGLT2is were low, although ACEi/ARB use was higher in patients with CKD + T2DM (42.4 %) vs CKD (27.7 %...
Type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular disease (ASCVD), and heart failure (HF)—along with their associated risk factors—have overlapping etiologies, and two or more of these conditions frequently occur in the same patient. Many recent cardiovascular out...
Management of hypertension in CKD: beyond the guidelines. Adv Chronic Kidney Dis. 2015;22(2):116–22. Article Google Scholar Christofides EA, Desai N. Optimal early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing. J...
Relationship between the lower limit of systolic blood pressure target and kidney function decline in advanced chronic kidney disease: an instrumental variable analysis from the REACH-J CKD cohort study. Hypertens Res. 2023;46:2478–87. Decker E, Kendrick J. Research in the CKD clinic: highs ...
Finerenone is approved for use in patients with CKD and T2D. Although several major multi-specialty guidelines strongly recommend finerenone to delay CKD progression and prevent HF events in people with CKD with T2D19,20,21, the latest Kidney Disease: Improving Global Outcomes (KDIGO) guideline...